Medical Univeristy of Lodz, Chair of Clinical Immunology and Rheumatology
Lodz, Łódź Voivodeship, 92-213, Poland
NCT Number: NCT04745429
In the past few years, research has provided evidence for a possibility of dampening immune system by one's will after undergoing a specific training program. Aim of this study was to verity the efficacy in affecting both mind and body by assessing psoriasis activity and psychological functioning. Among the members of both of the groups intensity of skin lesions and pruritus were assessed, consultation regarding treatment took place and multiple questionnaires regarding sleep quality, mindfulness and depressive symptoms were distributed. Blood samples were collected to asses intensity of inflammation, including interleukins.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
Lodz, Łódź Voivodeship, 92-213, Poland
Psoriasis is a skin disease of an unknown origin. Current understanding of its pathophysiology focuses on an undefined imbalance between the immune system and the nervous system. In this study the researchers assessed the effects of a training program which was proven to affect both. A group of psoriatic patients volunteered, and were randomized to either the intervention (n = 19), or control group (n = 19). Subjects in the intervention group were trained for 10 weeks in breathing techniques, exposure to cold and meditation. The control group was not trained.
After two weeks of the intervention, a full lockdown due to the COVID-19 pandemics was introduced. Modified protocol included exercises possible to conduct at home only.
Two study visits (before and after the intervention) took place.
Total count of variables analysed equaled 60. Primary endpoints regarded intensity of psoriasis. This group included laboratory markers (hsCRP, WBC, LEU, MONO, IL-6, IL-8, IL-10, IL-17, TNFalpha) measured in serum and saliva, visual skin assessment performed by a health professional using Psoriasis Area Severity Index, consultations regarding treatment, and results of the questionnaires (Dermatological Life Quality Index, pruritus). Secondary endpoints pertained comorbidities of psoriasis. These were also assessed using questionnaires, and included Pittsburgh Sleep Quality Index, Patient Health Questionnaire - 9 (depressive symptoms), Five Facet Mindfulness Questionnaire, Perceived Stress Scale - 10.
The intervention is a specific combination of breathing exercises, meditation and cold exposure. It has been previously proven to have an effect among healthy young males who were able to drop febrile temperatures induced with an intravenously distributed LPS. That phenomena was achieved using previously trained breathing techniques.
For 10 weeks members of the intervention group were trained via popular social media platform. Exercises included exposure to cold using regular, cold showers, performing breathing exercises finished with a short meditation session. Length and general difficulty were gradually built up.
Initially, total number of the subjects equaled 54. 31 for the intervention group and 23 for the control group. Due to drop-out or meeting the exclusion criteria, final count for both of the groups was 19 participants.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
It is a combination of exercises that include breathing exercises, cold exposure and meditation
Time frame: 10 weeks
Visual assessment of the skin condition. Extreme values: 0-72. The lower the score, the better
Time frame: 10 weeks
Questionnaire regarding the influence of the disease on everyday functioning. Extreme values: 0-30. The lower the value, the better.
Time frame: 10 weeks
Intensity of pruritus measured with a questionnaire. Extreme values 0-18. The lower the score, the better.
Time frame: 10 weeks
Change in ointment treatment - consultation result
Time frame: 10 weeks
Levels of C-reactive protein in serum using high sensitivity measurements
Time frame: 10 weeks
Level of interleukin 6 in measured serum
Time frame: 10 weeks
Level of interleukin 6 in measured saliva
Time frame: 10 weeks
Level of interleukin 8 measured in saliva
Time frame: 10 weeks
Levels of interleukin 8 measured in saliva
Time frame: 10 weeks
Levels of interleukin 10 measured in serum
Time frame: 10 weeks
Levels of interleukine 10 measured in saliva
Time frame: 10 weeks
Levels of Tumor Necrosis Factor in serum
Time frame: 10 weeks
Levels of Tumor Necrosis Factor in saliva
Time frame: 10 weeks
Monocyte count in peripheral blood morphology
Time frame: 10 weeks
Lymphocyte count in peripheral blood morphology
Time frame: 10 weeks
Platelet count in peripheral blood morphology
Time frame: 10 weeks
Neutrophil count in peripheral blood morphology
Time frame: 10 weeks
Total result of FFMQ. Extreme values: 39 - 195. The higher the score, the better.
Time frame: 10 weeks
Index regarding skill of restraining from labeling. Extreme values: 8-40. The higher the score, the better
Time frame: 10 weeks
Index measuring skill of restraining from uncontrolled reactions. Extreme values: 7-35. The higher the score, the better
Time frame: 10 weeks
Index regarding objective observation. Extreme values: 8-40. The higher the score, the better
Time frame: 10 weeks
Index regarding everyday awareness. Extreme values: 8-40. The higher the score, the better
Time frame: 10 weeks
Index regarding skill of objective describing. Extreme values: 8-40. The higher the score, the better
Time frame: 10 weeks
Questionnaire regarding everyday stress. Extreme values 0-40. The lower the score, the better.
Time frame: 10 weeks
Questionnaire regarding depressive symptoms. Extreme values 0 - 27. The lower the score, the better
Time frame: 10 weeks
Questionnaire regarding sleep quality. Extreme values 0 - 21, the lower the score, the better
Medical University of Lodz
Other
Combination of Breathing Exercises, Cold Exposure, and Meditation Mitigate Psoriasis - Open Label, Randomized, Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05506644
Anxiety, Anxiety Disorders
San Diego, California, United States
View Trial DetailsNCT01778569
Cardiovascular Disease, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT04776629
Arterial Occlusive Diseases, Arteriosclerosis
Scottsdale, Arizona, United States
View Trial DetailsNCT06800755
Dry Skin, Pathological Conditions, Signs and Symptoms
Gdansk, Poland
View Trial Details